Product Program year 2025 Source: CMS Open Payments

Aldara

Drug Dermatology

NDC 99207-260-12

Open in the dashboard

General payments

$1,491

68 payments

Research payments

$0

0 payments

Through program year 2025, $1,491 in general payments and $0 in research payments were reported against Aldara (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $456 4
2024 General $71 5
2022 General $24 1
2020 General $40 2
2019 General $900 56

Breakdown

Who paid General payments · program years 2019–2025
  1. Ortho Dermatologics, a division of Bausch Health US, LLC $964 59 payments
  2. Salix Pharmaceuticals, a division of Bausch Health US, LLC $527 9 payments
Top recipients General payments · program year 2025
  1. Fred Defrancesch Physical Medicine & Rehabilitation · Metairie, LA $114 25% · 1 payment
  2. Robert Nicholson Hammond, LA $114 25% · 1 payment
  3. Jay Napolitano Pain Medicine · Metairie, LA $114 25% · 1 payment
  4. Waleed Sultan Family Medicine · Johnstown, PA $114 25% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Family Medicine $114 33% · 1 practitioner
  2. Pain Medicine Physical Medicine & Rehabilitation $114 33% · 1 practitioner
  3. Physical Medicine & Rehabilitation $114 33% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Louisiana $342 75% · 3 recipients
  2. Pennsylvania $114 25% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

68 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record